ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

In Congress; Senate Ok’s $185 Mil. Addition For Breast Cancer

October 2, 1992

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

February 2, 2007

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003